We've found
14,731
archived clinical trials in
Psychiatric
We've found
14,731
archived clinical trials in
Psychiatric
Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol
Updated: 8/4/2015
The Mission Connect Mild TBI Translational Research Consortium's Integrated Clinical Protocol
Status: Enrolling
Updated: 8/4/2015
Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol
Updated: 8/4/2015
The Mission Connect Mild TBI Translational Research Consortium's Integrated Clinical Protocol
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials

Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol
Updated: 8/4/2015
The Mission Connect Mild TBI Translational Research Consortium's Integrated Clinical Protocol
Status: Enrolling
Updated: 8/4/2015
Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol
Updated: 8/4/2015
The Mission Connect Mild TBI Translational Research Consortium's Integrated Clinical Protocol
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials

Minocycline for Bipolar Depression
Updated: 8/4/2015
Minocycline for Bipolar Disorder
Status: Enrolling
Updated: 8/4/2015
Minocycline for Bipolar Depression
Updated: 8/4/2015
Minocycline for Bipolar Disorder
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials

Effect of CPAP on Postoperative Delirium
Updated: 8/4/2015
The Effect of Peri-operative Continuous Positive Airway Pressure (CPAP) on Postoperative Delirium in a Population at High-risk for Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 8/4/2015
Effect of CPAP on Postoperative Delirium
Updated: 8/4/2015
The Effect of Peri-operative Continuous Positive Airway Pressure (CPAP) on Postoperative Delirium in a Population at High-risk for Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials

Developing Violence Prevention Therapy for Substance Abusers
Updated: 8/4/2015
Development of Violence Therapy for Substance Abusers
Status: Enrolling
Updated: 8/4/2015
Developing Violence Prevention Therapy for Substance Abusers
Updated: 8/4/2015
Development of Violence Therapy for Substance Abusers
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials

Effectiveness of a Web-based Intervention for Guardians of Children Whose One Parent Has Murdered the Other
Updated: 8/5/2015
Testing an IHCA for Guardians of Survivors of Intraparental Homicide
Status: Enrolling
Updated: 8/5/2015
Effectiveness of a Web-based Intervention for Guardians of Children Whose One Parent Has Murdered the Other
Updated: 8/5/2015
Testing an IHCA for Guardians of Survivors of Intraparental Homicide
Status: Enrolling
Updated: 8/5/2015
Click here to add this to my saved trials

Effect Of Biomechanical Stimulation On Skeletal Health In Adolescent And Young Women With Anorexia Nervosa
Updated: 8/5/2015
EFFECT OF BIOMECHANICAL STIMULATION ON SKELETAL HEALTH IN ADOLESCENT AND YOUNG WOMEN WITH ANOREXIA NERVOSA
Status: Enrolling
Updated: 8/5/2015
Effect Of Biomechanical Stimulation On Skeletal Health In Adolescent And Young Women With Anorexia Nervosa
Updated: 8/5/2015
EFFECT OF BIOMECHANICAL STIMULATION ON SKELETAL HEALTH IN ADOLESCENT AND YOUNG WOMEN WITH ANOREXIA NERVOSA
Status: Enrolling
Updated: 8/5/2015
Click here to add this to my saved trials

A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse
Updated: 8/5/2015
A Randomized, Double-blind, Placebo-controlled, Dose of RBP-8000 Following IV Cocaine to Evaluate the Pharmacokinetics Parameters of RBP-8000 and Cocaine and to Assess the Effects of Drug on Cocaine-induced Physiologic and Behavioral Effects in Cocaine Abusing Subjects
Status: Enrolling
Updated: 8/5/2015
A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse
Updated: 8/5/2015
A Randomized, Double-blind, Placebo-controlled, Dose of RBP-8000 Following IV Cocaine to Evaluate the Pharmacokinetics Parameters of RBP-8000 and Cocaine and to Assess the Effects of Drug on Cocaine-induced Physiologic and Behavioral Effects in Cocaine Abusing Subjects
Status: Enrolling
Updated: 8/5/2015
Click here to add this to my saved trials

Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder
Updated: 8/6/2015
A Randomized, Double-Blind, Placebo Controlled Study Of Quetiapine SR (QTP) As Adjunctive Treatment In Mixed States (MS) Of Bipolar Disorder
Status: Enrolling
Updated: 8/6/2015
Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder
Updated: 8/6/2015
A Randomized, Double-Blind, Placebo Controlled Study Of Quetiapine SR (QTP) As Adjunctive Treatment In Mixed States (MS) Of Bipolar Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Updated: 8/6/2015
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

Whole Body Hyperthermia & Combat-Related Posttraumatic Stress Disorder (PTSD)
Updated: 8/6/2015
Whole Body Hyperthermia & Combat-Related Posttraumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/6/2015
Whole Body Hyperthermia & Combat-Related Posttraumatic Stress Disorder (PTSD)
Updated: 8/6/2015
Whole Body Hyperthermia & Combat-Related Posttraumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 8/6/2015
Click here to add this to my saved trials

Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness
Updated: 8/7/2015
CBT for PTSD and SMI in Community Mental Health Centers
Status: Enrolling
Updated: 8/7/2015
Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness
Updated: 8/7/2015
CBT for PTSD and SMI in Community Mental Health Centers
Status: Enrolling
Updated: 8/7/2015
Click here to add this to my saved trials

Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness
Updated: 8/7/2015
CBT for PTSD and SMI in Community Mental Health Centers
Status: Enrolling
Updated: 8/7/2015
Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness
Updated: 8/7/2015
CBT for PTSD and SMI in Community Mental Health Centers
Status: Enrolling
Updated: 8/7/2015
Click here to add this to my saved trials

Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury
Updated: 8/10/2015
Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury
Status: Enrolling
Updated: 8/10/2015
Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury
Updated: 8/10/2015
Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials

Mindfulness: a Novel Approach for the Management of Diabetes-related Distress
Updated: 8/10/2015
Mindfulness: a Novel Approach for the Management of Diabetes-related Distress
Status: Enrolling
Updated: 8/10/2015
Mindfulness: a Novel Approach for the Management of Diabetes-related Distress
Updated: 8/10/2015
Mindfulness: a Novel Approach for the Management of Diabetes-related Distress
Status: Enrolling
Updated: 8/10/2015
Click here to add this to my saved trials

Long-term Behavior Change - 1
Updated: 8/11/2015
Behavior Change: Reinforcement Schedule Effects
Status: Enrolling
Updated: 8/11/2015
Long-term Behavior Change - 1
Updated: 8/11/2015
Behavior Change: Reinforcement Schedule Effects
Status: Enrolling
Updated: 8/11/2015
Click here to add this to my saved trials

Long-term Behavior Change - 1
Updated: 8/11/2015
Behavior Change: Reinforcement Schedule Effects
Status: Enrolling
Updated: 8/11/2015
Long-term Behavior Change - 1
Updated: 8/11/2015
Behavior Change: Reinforcement Schedule Effects
Status: Enrolling
Updated: 8/11/2015
Click here to add this to my saved trials

Treatment of Older Veterans With Chronic Posttraumatic Stress Disorder
Updated: 8/11/2015
Treatment of Older Veterans With Chronic Posttraumatic Stress Disorder
Status: Enrolling
Updated: 8/11/2015
Treatment of Older Veterans With Chronic Posttraumatic Stress Disorder
Updated: 8/11/2015
Treatment of Older Veterans With Chronic Posttraumatic Stress Disorder
Status: Enrolling
Updated: 8/11/2015
Click here to add this to my saved trials

Treatment of Sleep Disturbances in Young Children With Autism
Updated: 8/11/2015
Treatment of Sleep Disturbances in Young Children With Autism
Status: Enrolling
Updated: 8/11/2015
Treatment of Sleep Disturbances in Young Children With Autism
Updated: 8/11/2015
Treatment of Sleep Disturbances in Young Children With Autism
Status: Enrolling
Updated: 8/11/2015
Click here to add this to my saved trials

Computerized Brief Intervention vs. Delayed Computerized Brief Intervention
Status: Enrolling
Updated: 8/11/2015
Updated: 8/11/2015
Computerized Brief Intervention vs. Delayed Computerized Brief Intervention
Status: Enrolling
Updated: 8/11/2015
Updated: 8/11/2015
Click here to add this to my saved trials

Treating Co-Morbid Sleep Difficulties in Veterans With Posttraumatic Stress Disorder (PTSD): A Pilot Study
Updated: 8/11/2015
Treating Co-Morbid Sleep Difficulties in Veterans With PTSD: A Pilot Study
Status: Enrolling
Updated: 8/11/2015
Treating Co-Morbid Sleep Difficulties in Veterans With Posttraumatic Stress Disorder (PTSD): A Pilot Study
Updated: 8/11/2015
Treating Co-Morbid Sleep Difficulties in Veterans With PTSD: A Pilot Study
Status: Enrolling
Updated: 8/11/2015
Click here to add this to my saved trials

WalkLink: Internet-based Walking Program
Updated: 8/12/2015
WalkLink:Internet-based Walking Program for Cardiovascular Disease Risk-Reduction
Status: Enrolling
Updated: 8/12/2015
WalkLink: Internet-based Walking Program
Updated: 8/12/2015
WalkLink:Internet-based Walking Program for Cardiovascular Disease Risk-Reduction
Status: Enrolling
Updated: 8/12/2015
Click here to add this to my saved trials

College Students Who Self-Harm
Updated: 8/12/2015
College Students Who Self-Harm: An Intervention Study
Status: Enrolling
Updated: 8/12/2015
College Students Who Self-Harm
Updated: 8/12/2015
College Students Who Self-Harm: An Intervention Study
Status: Enrolling
Updated: 8/12/2015
Click here to add this to my saved trials

Treatment of Cocaine Dependence With Lisdexamfetamine
Updated: 8/13/2015
Lisdexamfetamine Treatment for Cocaine Dependence
Status: Enrolling
Updated: 8/13/2015
Treatment of Cocaine Dependence With Lisdexamfetamine
Updated: 8/13/2015
Lisdexamfetamine Treatment for Cocaine Dependence
Status: Enrolling
Updated: 8/13/2015
Click here to add this to my saved trials

One-Day Acceptance and Commitment Training Intervention in Primary Care Patients
Updated: 8/13/2015
One-Day Acceptance and Commitment Training Intervention in Primary Care Patients
Status: Enrolling
Updated: 8/13/2015
One-Day Acceptance and Commitment Training Intervention in Primary Care Patients
Updated: 8/13/2015
One-Day Acceptance and Commitment Training Intervention in Primary Care Patients
Status: Enrolling
Updated: 8/13/2015
Click here to add this to my saved trials
